Case study interpretation--Fort Lauderdale: Case 3.

about

Case study interpretation--Fort Lauderdale: Case 3.

Item

http://www.wikidata.org/entity/Q54364092

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Case study interpretation--Fort Lauderdale: Case 3.

@en

Case study interpretation--Fort Lauderdale: Case 3.

@nl

type

Item

label

Case study interpretation--Fort Lauderdale: Case 3.

@en

Case study interpretation--Fort Lauderdale: Case 3.

@nl

prefLabel

Case study interpretation--Fort Lauderdale: Case 3.

@en

Case study interpretation--Fort Lauderdale: Case 3.

@nl

P1476

Case study interpretation--Fort Lauderdale: Case 3.

@en

P2093

Eunice Wang

http://www.w3.org/2001/XMLSchema#string

George Deeb

http://www.w3.org/2001/XMLSchema#string

Paul Wallace

http://www.w3.org/2001/XMLSchema#string

P2860

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations.

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.

Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B.

Targeting levels or oligomerization of nucleophosmin 1 induces differentiation and loss of survival of human AML cells with mutant NPM1.

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

FLT3 as a therapeutic target in AML: still challenging after all these years

How I treat acute promyelocytic leukemia.

Flt3 mutations and leukaemia.

Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?

Terminal myeloid differentiation in vivo is induced by FLT3 inhibition in FLT3/ITD AML.

P304

404-407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CYTO.B.21152

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24677776

http://www.w3.org/2001/XMLSchema#string